MBX BIOSCIENCES INC (MBX) Stock Income Statement
USA - NASDAQ:MBX - US55287L1017 - Common Stock
17 USD
+0.87 (+5.39%)
17 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 86.56M | 68.19M | 35.31M | 25.16M | |||
| Research and Development | 72.10M | 57.41M | 28.53M | 21.40M | |||
| Selling, General, and Administrative Expenses | 14.46M | 10.78M | 6.78M | 3.76M | |||
| Operating Income | -86.56M | -68.19M | -35.31M | -25.16M | |||
| Interest Income/Expense | 9.54M | 6.27M | 2.75M | -75.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | -899.00K | |||
| Income Before Taxes | -77.02M | -61.92M | -32.56M | -26.14M | |||
| Net Income | -77.02M | -61.92M | -32.56M | -26.14M | |||
| EBITDA | -86.28M | -67.95M | -35.15M | -25.11M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -3.30 | -5.82 | -1.02 | -0.82 | |||
| Non GAAP EPS | -4.54 | N/A | N/A | N/A | |||
| Statistics | |||||||
All data in USD